This year, headlines in the cell and gene therapy landscape have so far been dominated by Sarepta. The biotech’s Duchenne muscular dystrophy treatment Elevidys (delandistrogene moxeparvovec) became ...

Albino cane toads created using gene-editing technology reveal that albino animals face competitive disadvantages going far ...

The emergence of AlphaCD brings new possibilities for gene editing technology. By learning and analyzing large-scale experimental data, this model can accurately predict enzyme activity and, based on ...

NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...

As the first wave of gene therapies for transfusion-dependent β-thalassemia (TDT) continues to roll out in the U.S., a new conversation is emerging within the hematology community: whether the future ...

Treatment with exagamglogene autotemcel (exa-cel) led to robust and sustained improvements in quality of life for patients ...

There's a fresh push to edit the genes of human embryos to prevent diseases and enhance characteristics that parents value.

The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates ...

The idea of bringing back extinct species has gained traction thanks to advances in sequencing of ancient DNA. In recent years, scientists have recovered genetic blueprints from the remains of ...

Researchers at The Ohio State University Wexner Medical Center are using novel nonviral gene therapy technology to gain ...

The latest announcement is out from Bio-Gene Technology Ltd. ( ($AU:BGT) ). Bio-Gene Technology Limited released its 2025 Annual Report, ...

Bio-Gene Technology Ltd. ( ($AU:BGT) ) has issued an announcement. Bio-Gene Technology Ltd. has released its Corporate Governance Statement, ...